371 related articles for article (PubMed ID: 30567732)
41. HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy.
Deng S; Hu Q; Zhang H; Yang F; Peng C; Huang C
Mol Cancer Ther; 2019 May; 18(5):900-908. PubMed ID: 30824609
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of PD-L1 and PD-L2 in dermal fibroblasts from alopecia areata mice.
Li Y; Kilani RT; Pakyari M; Leung G; Nabai L; Ghahary A
J Cell Physiol; 2018 Mar; 233(3):2590-2601. PubMed ID: 28777458
[TBL] [Abstract][Full Text] [Related]
43. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
44. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers.
Zhao Q; Guo J; Zhao Y; Shen J; Kaboli PJ; Xiang S; Du F; Wu X; Li M; Wan L; Li X; Wen Q; Li J; Zou C; Xiao Z
Epigenomics; 2020 Dec; 12(24):2155-2171. PubMed ID: 33337915
[No Abstract] [Full Text] [Related]
46. Differential regulation of germinal center genes, BCL6 and SWAP-70, during the course of MAIDS.
Qi CF; Jessberger R; Torrey TA; Taddesse-Heath L; Ohta Y; Morse HC
Mol Immunol; 1999; 36(15-16):1043-53. PubMed ID: 10698307
[TBL] [Abstract][Full Text] [Related]
47. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.
Cattoretti G; Shaknovich R; Smith PM; Jäck HM; Murty VV; Alobeid B
J Immunol; 2006 Nov; 177(10):6930-9. PubMed ID: 17082608
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of PI3Kδ Differentially Regulates Poly I:C- and Human Metapneumovirus-Induced PD-L1 and PD-L2 Expression in Human Bronchial Epithelial Cells.
Ogawa T; Kan-O K; Shiota A; Fujita A; Ishii Y; Fukuyama S; Matsumoto K
Front Immunol; 2021; 12():767666. PubMed ID: 34899719
[TBL] [Abstract][Full Text] [Related]
49. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.
Niu H; Cattoretti G; Dalla-Favera R
J Exp Med; 2003 Jul; 198(2):211-21. PubMed ID: 12860928
[TBL] [Abstract][Full Text] [Related]
50. Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Qi J; Luznik L; Maillard I; MacDonald KP; Hill GR; Serody JS; Murphy WJ; Sage PT; Sharpe AH; Miklos D; Cutler CS; Koreth J; Antin JH; Soiffer RJ; Ritz J; Bradner JE; Melnick AM; Blazar BR
Blood; 2019 Jan; 133(1):94-99. PubMed ID: 30279226
[TBL] [Abstract][Full Text] [Related]
51. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
[TBL] [Abstract][Full Text] [Related]
52. Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function.
Sage PT; Schildberg FA; Sobel RA; Kuchroo VK; Freeman GJ; Sharpe AH
J Immunol; 2018 Apr; 200(8):2592-2602. PubMed ID: 29531164
[TBL] [Abstract][Full Text] [Related]
53. CD4 memory T cells develop and acquire functional competence by sequential cognate interactions and stepwise gene regulation.
Kaji T; Hijikata A; Ishige A; Kitami T; Watanabe T; Ohara O; Yanaka N; Okada M; Shimoda M; Taniguchi M; Takemori T
Int Immunol; 2016 Jun; 28(6):267-82. PubMed ID: 26714588
[TBL] [Abstract][Full Text] [Related]
54. An Inhibitory Role for the Transcription Factor Stat3 in Controlling IL-4 and Bcl6 Expression in Follicular Helper T Cells.
Wu H; Xu LL; Teuscher P; Liu H; Kaplan MH; Dent AL
J Immunol; 2015 Sep; 195(5):2080-9. PubMed ID: 26188063
[TBL] [Abstract][Full Text] [Related]
55. Extrafollicular CD4
Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.
Ishida M; Iwai Y; Tanaka Y; Okazaki T; Freeman GJ; Minato N; Honjo T
Immunol Lett; 2002 Oct; 84(1):57-62. PubMed ID: 12161284
[TBL] [Abstract][Full Text] [Related]
57. The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals.
Philips EA; Garcia-España A; Tocheva AS; Ahearn IM; Adam KR; Pan R; Mor A; Kong XP
J Biol Chem; 2020 Apr; 295(14):4372-4380. PubMed ID: 31882544
[TBL] [Abstract][Full Text] [Related]
58. PD-1 Controls Follicular T Helper Cell Positioning and Function.
Shi J; Hou S; Fang Q; Liu X; Liu X; Qi H
Immunity; 2018 Aug; 49(2):264-274.e4. PubMed ID: 30076099
[TBL] [Abstract][Full Text] [Related]
59. Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage.
Hagiwara Y; Sato H; Permata TBM; Niimi A; Yamauchi M; Oike T; Nakano T; Shibata A
Hum Immunol; 2018 Aug; 79(8):627-631. PubMed ID: 29859207
[TBL] [Abstract][Full Text] [Related]
60. Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-
Moriyama R; Katsumata Y; Okamoto Y; Harigai M
Lupus; 2024 Jul; 33(8):816-827. PubMed ID: 38622764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
